Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future.
Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome.
Psoriasis and comorbidities. Epidemiological studies.
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
Tysabri may be option for kids with MS
Mitochondrial DNA T4216C and A4917G variations in multiple sclerosis.
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ-independent fashion and during development.
MxA mRNA expression as a biomarker of interferon beta response in multiple sclerosis patients.
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.
Characteristics, diagnosis and outcome of patients referred to a specialized neurology emergency clinic: prospective observational study.
Pain in acquired inflammatory demyelinating polyneuropathies.
Characterization of Compensatory Stepping in People with Multiple Sclerosis.
Evaluation of plaque detection and optimum time of enhancement in acute attack multiple sclerosis after contrast injection.
Requirement for safety monitoring for approved MS therapies - An overview.
Molecular Architecture of Myelinated Nerve Fibers: Leaky Paranodal Junctions and Paranodal Dysmyelination.
Changes in normal appearing spinal cord in multiple sclerosis: another brick in the wall.
Cortical Thinning Correlates with Cognitive Change in Multiple Sclerosis but not in Neuromyelitis Optica.
Cognitive-Motor Interference in Multiple Sclerosis: A Systematic Review of Evidence, Correlates, and Consequences.
There is no evidence to support or refute the effectiveness of memory rehabilitation on memory function or functional abilities in people with multiple sclerosis.
The astrocyte in multiple sclerosis revisited.
Abnormalities of the executive control network in multiple sclerosis phenotypes: An fMRI effective connectivity study.
Type I interferons regulate the magnitude and functionality of mouse polyomavirus-specific CD8 T cells in a viral strain-dependent manner.
Spatio-Temporal Patterns of Demyelination and Remyelination in the Cuprizone Mouse Model.
Prevention and Mitigation of Experimental Autoimmune Encephalomyelitis by Murine β-Defensins via Induction of Regulatory T Cells.
Pages
« first
‹ previous
…
667
668
669
670
671
672
673
674
675
…
next ›
last »